Marinus Pharmaceuticals, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 7.19 million compared to USD 7.16 million a year ago. Net loss was USD 41.77 million compared to USD 34.31 million a year ago. Basic loss per share from continuing operations was USD 0.74 compared to USD 0.76 a year ago.

For the full year, the company reported revenue was USD 30.99 million compared to USD 25.48 million a year ago. Net loss was USD 141.41 million compared to USD 19.82 million a year ago. Basic loss per share from continuing operations was USD 2.63 compared to USD 0.51 a year ago.